Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors

American Journal of Psychiatry

Volumn 153, Issue 6, 1996, Pages 820-822

  Centorrino, Franca ^a   Baidessarini, Ross J ^b   Frankenburg, Frances R ^b   Kando, Judith ^b   Volpicelli, Sheila A ^b   Flood, James G ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; DRUG METABOLITE; FLUOXETINE; LITHIUM; NORCLOZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SCHIZOPHRENIA;

EID: 0029953653     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.6.820     Document Type: Article

References (10)

1. Baldessarini RJ, Frankenburg FR: Clozapine - a novel antipsychotic agent. N Engl J Med 1991; 324:746-754
2. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM: Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 1993; 9:117-124
3. Centorrino F, Baldessarini RJ, Kando J, Frankenburg FR, Volpicelli SA, Puopolo PR, Flood JG: Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry 1994; 151:123-125
4. DeVane CL: Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 1994; 97(suppl 6A):13S-23S
5. Pollock B: Recent developments in drug metabolism of relevance to psychiatrists. Harvard Rev Psychiatry 1994; 2:204-213
6. Popli AP, Baldessarini RJ, Cole JO: Interactions of serotonin reuptake inhibitors with tricyclic antidepressants (letter). Arch Gen Psychiatry 1994; 51:666-667
7. Slaughter RL, Edwards DJ: Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995; 29:619-624
8. Gorski JC, Jones DR, Wrighton SA, Hall SD: Characterization of dextromethorphan N-demethylation by human liver microsomes: contribution of the cytochrome P450 3A (CYP3A) subfamily. Biochem Pharmacol 1994; 48:173-182
9. Jerling M, Lindstrom L, Bondesson U, Bertilsson L: Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Thcr Drug Monit 1994; 16:368-374
10. Preskorn SH, Alderman J, Cheung M, Messig M, Harris S: Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J Clin Psychopharmacol 1994; 14:90-98